The goal is preserving strength, mobility, and metabolic tissue
Heiss, C
Unlike previous generations of weight loss medications that target one or two hormonal pathways, Retatrutide simultaneously activates three distinct receptor systems, creating a synergistic fat-burning effect that clinical trials show outperforms every other pharmaceutical intervention tested to date
3,4 In fact, one study found that hair thinning was reported in almost 7% of people taking high-dose oral semaglutide, compared to less than 1% on placebo
Burns also noted that in 2024, Wegovy, Zepbound, and Ozempic had nearly half a billion dollars in advertising behind them, and asked a fair question: if these drugs work so well, why the need to market them so aggressively
This work is the result of NIH funding, in part, and is subject to the NIH Public Access Policy